Med24
metabolic-therapy 13. 10. 2026 • 2 min read • Frontiers in endocrinology (PubMed)

Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait.

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common comorbidity in individuals with type 2 diabetes mellitus (T2DM). Given the high prevalence of T2DM in Kuwait and limited regional data on hepatic steatosis, this study aimed to assess the prevalence and severity of liver steatosis...

Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait.

A study was conducted to assess the prevalence and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with type 2 diabetes mellitus (T2DM) attending the Dasman Diabetes Institute (DDI) in Kuwait. The study evaluated 267 T2DM patients, with a mean age of 53.2 years and a male predominance (67.4%).

Prevalence of Liver Steatosis and Fibrosis

Liver steatosis (S0-S3) was identified in 72.7% of participants. Forty-eight point eight percent exhibited severe steatosis (S3), twenty-one point six percent moderate steatosis (S2), and eleven point two percent mild steatosis (S1). Minimal or no fibrosis (F0-F1) was present in ninety-two point five percent of the cohort. Moderate fibrosis (F2) was observed in four point one percent, and advanced fibrosis (F3-F4) was identified in three point four percent.

Sponsored content

Biomarker Associations

Vibration-controlled transient elastography (VCTE) using controlled attenuation parameter (CAP) scores was utilized to determine liver steatosis and estimate fibrosis severity via liver stiffness measurement (LSM). Significant positive associations were found between CAP scores and BMI (ρ = 0.32, p < 0.001), waist circumference (ρ = 0.200, p = 0.001), triglycerides (ρ = 0.310, p < 0.001), ALT (ρ = 0.325, p < 0.001), AST (ρ = 0.197, p = 0.002), and GGT (ρ = 0.203, p = 0.001). An inverse correlation was observed with HDL-C (ρ = -0.19, p = 0.003). CAP score remained independently associated with BMI, ALT, and LSM in multivariable linear regression analyses. LSM was significantly associated with CAP score, BMI, ALT, AST, and GGT.

Original Scientific Source
Frontiers in endocrinology (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement